In addition, studies have shown that TLR4 antagonists can decrease the creation of pro-inflammatory factors and alleviate motor dysfunction in mouse models of experimental autoimmune encephalomyelitis [31]. This evidence concerns the gene TLR4 and experimental autoimmune encephalomyelitis.